Prohledat tento blog

čtvrtek 5. dubna 2018

Tumor doubling time and prognosis in lung cancer patients: evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening... - PubMed - NCBI

Tumor doubling time and prognosis in lung cancer patients: evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening... - PubMed - NCBI:

Tumor doubling time and prognosis in lung cancer patients: evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening... - PubMed - NCBI

Tumor doubling time was calculated in 237 patients from two serial chest x-ray films. 
The mean doubling time was 166.3 days, with 

  • 221.6 days for adenocarcinoma, 
  • 115.2 days for squamous cell carcinoma, 
  • 67.5 days for large cell carcinoma, 8
  • 6.3 days for small cell carcinoma....

Žádné komentáře:

Okomentovat

High Prevalence of PD-L1 Expression in Non-Small-cell Lung Cancer

High Prevalence of PD-L1 Expression in Non-Small-cell Lung Cancer : .....For the EXPRESS study, online June 12 in Lung Cancer, Dr. Diet...

Translate